Chronic Myeloid Leukemia Stem Cells: Now on the Run

被引:4
作者
Goldman, John M. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Dept Haematol, London, England
关键词
CHRONIC MYELOGENOUS LEUKEMIA; IMATINIB; RESPONSES;
D O I
10.1200/JCO.2008.19.2260
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:313 / 314
页数:3
相关论文
共 8 条
[1]   BCR-ABL messenger RNA levels continue to decline in patients with chronic phase chronic myeloid leukemia treated with imatinib for more than 5 years and approximately half of all first-line treated patients have stable undetectable BCR-ABL using strict sensitivity criteria [J].
Branford, Susan ;
Seymour, John F. ;
Grigg, Andrew ;
Arthur, Chris ;
Rudzki, Zbigniew ;
Lynch, Kevin ;
Hughes, Timothy .
CLINICAL CANCER RESEARCH, 2007, 13 (23) :7080-7085
[2]   Imatinib for newly diagnosed patients with chronic myeloid leukemia: Incidence of sustained responses in an intention-to-treat analysis [J].
de Lavallade, Hugues ;
Apperley, Jane F. ;
Khorashad, Jamshid S. ;
Milojkovic, Dragana ;
Reid, Alistair G. ;
Bua, Marco ;
Szydlo, Richard ;
Olavarria, Eduardo ;
Kaeda, Jaspal ;
Goldman, John M. ;
Marin, David .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (20) :3358-3363
[3]   Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia [J].
Druker, Brian J. ;
Guilhot, Francois ;
O'Brien, Stephen G. ;
Gathmann, Insa ;
Kantarjian, Hagop ;
Gattermann, Norbert ;
Deininger, Michael W. N. ;
Silver, Richard T. ;
Goldman, John M. ;
Stone, Richard M. ;
Cervantes, Francisco ;
Hochhaus, Andreas ;
Powell, Bayard L. ;
Gabrilove, Janice L. ;
Rousselot, Philippe ;
Reiffers, Josy ;
Cornelissen, Jan J. ;
Hughes, Timothy ;
Agis, Hermine ;
Fischer, Thomas ;
Verhoef, Gregor ;
Shepherd, John ;
Saglio, Giuseppe ;
Gratwohl, Alois ;
Nielsen, Johan L. ;
Radich, Jerald P. ;
Simonsson, Bengt ;
Taylor, Kerry ;
Baccarani, Michele ;
So, Charlene ;
Letvak, Laurie ;
Larson, Richard A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (23) :2408-2417
[4]   Why do chronic myelogenous leukemia stem cells survive allogeneic stem cell transplantation or imatinib: does it really matter? [J].
Goldman, J ;
Gordon, M .
LEUKEMIA & LYMPHOMA, 2006, 47 (01) :1-7
[5]   Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia [J].
Hughes, TP ;
Kaeda, J ;
Branford, S ;
Rudzki, Z ;
Hochhaus, A ;
Hensley, ML ;
Gathmann, I ;
Bolton, AE ;
van Hoomissen, IC ;
Goldman, JM ;
Radich, JP ;
Taylor, K ;
Durrant, S ;
Schwarer, A ;
Joske, D ;
Seymour, J ;
Grigg, A ;
Ma, D ;
Arthur, C ;
Bradstock, K ;
Joshua, D ;
Lechner, K ;
Verhoef, G ;
Louwagie, A ;
Martiat, P ;
Straetmans, N ;
Bosly, A ;
Shepherd, J ;
Shustik, C ;
Lipton, J ;
Kovacs, DM ;
Turner, AR ;
Nielsen, JL ;
Birgens, H ;
Bjerrum, OW ;
Guilhot, F ;
Reiffers, J ;
Rousselot, P ;
Facon, T ;
Harousseau, JL ;
Tulliez, M ;
Guerci, A ;
Blaise, D ;
Maloisel, F ;
Michallet, M ;
Fischer, T ;
Hossfeld, D ;
Mertelsmann, R ;
Andreesen, R ;
Nerl, C .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (15) :1423-1432
[6]   Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML [J].
Jamieson, CHM ;
Ailles, LE ;
Dylla, SJ ;
Muijtjens, M ;
Jones, C ;
Zehnder, JL ;
Gotlib, J ;
Li, K ;
Manz, MG ;
Keating, A ;
Sawyers, CL ;
Weissman, IL .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (07) :657-667
[7]   Chronic myeloid leukemia stem cells [J].
Kavalerchik, Edward ;
Goff, Daniel ;
Jamieson, Catriona H. M. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (17) :2911-2915
[8]   Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years [J].
Rousselot, Philippe ;
Huguet, Francoise ;
Rea, Delphine ;
Legros, Laurence ;
Cayuela, Jean Michel ;
Maarek, Odile ;
Blanchet, Odile ;
Marit, Gerald ;
Gluckman, Eliane ;
Reiffers, Josy ;
Gardembas, Martine ;
Mahon, Francois-Xavier .
BLOOD, 2007, 109 (01) :58-60